Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2010
10/14/2010US20100261271 Regulation of endogenous gene expression in cells using zinc finger proteins
10/14/2010US20100261210 Compositions and methods for diagnosing and treating prostate cancer
10/14/2010US20100260843 Regeneration and repair of neural tissue using postpartum-derived cells
10/14/2010US20100260807 Methods of Inducing and/or Enhancing an Immune Response To Tumor Antigens
10/14/2010US20100260800 AVV Vectors and Methods
10/14/2010US20100260761 Antibodies specifically reactive with a tumor necrosis factor related ligand
10/14/2010US20100260734 Method of stimulating prosaposin receptor activity
10/14/2010CA2757088A1 Neuron generation, regeneration and protection
10/14/2010CA2756833A1 Targeted integration into stem cells
10/14/2010CA2754412A1 Differentially expressed micrornas as biomarkers for the diagnosis and treatment of sjogren's syndrome
10/13/2010EP2239340A2 Identification of surface-oriented antigens for tumour diagnosis and treatment
10/13/2010EP2239330A1 Neuron generation, regeneration and protection
10/13/2010EP2239329A1 Therapeutic compositions
10/13/2010EP2239321A1 Clearance of ras-mediated neoplastic cells from mixed cellular compositions using reovirus
10/13/2010EP2238987A1 Sugar chain-related gene and use thereof
10/13/2010EP1694852B1 Mutant herpes simplex virus and use thereof in the treatment of squamous cell cancer
10/13/2010EP1503785B1 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
10/13/2010EP1487274B1 Tissue engineering
10/13/2010CN1896100B Liver regenerated factor and its use
10/13/2010CN101861162A Method for treating cancer via the mucosal administration of interleukin
10/13/2010CN101857862A Let-7c gene fragment and miR-99+Let-7c coexpression gene fragment and application thereof
10/13/2010CN101857861A Molecular marker for immunological recognition and construction and application thereof
10/13/2010CN101857860A Application of viral nucleic acid sequence strictly conservative area as siRNA design template
10/13/2010CN101856501A Tumor targeted molecular chemotherapeutic gene-virus preparation SG500-deoxyribonucleoside kinase of drosophila melanogaster (SG500-Dm-dNK) and building method and application thereof
10/13/2010CN101275132B SiRNA capable of inhibiting influenza A virus replication and coding sequence thereof
10/13/2010CN101205538B Clone, expression and use of Schistosoma Japonicum signal transduction protein Sjwnt-4 gene
10/13/2010CN101070349B Fusion protein with function of selective killing endothelial cells in tumor neogenetic blood vessels and use thereof
10/13/2010CN101054413B Tumor correlated albumen, coding gene and application thereof
10/12/2010US7812149 Comprises nucleotide sequences for use in gene expression inhibition, viral defense, transposon silencing and treatment of metabolic disorders; antisense agents
10/12/2010US7812148 Vectors comprising CpG islands without position effect varigation and having increased expression
10/12/2010US7812146 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
10/12/2010US7812136 useful for monitoring the (de)activation status if the patient is treated with thrombocyte aggregation inhibitors
10/12/2010US7812003 Antisense microRNA and uses therefor
10/12/2010US7811820 Generation, maintenance vascular system tissue; controlling gene expression; cardiovascular disorders
10/12/2010US7811818 Hepatocyte culture for use monitoring liver metabolism and diagnosing liver disorders; useful in transplantation, for experimental evaluation, and as a source of lineage and cell specific products
10/12/2010US7811814 for nervous system disorder; includes a first nucleic acid, a second nucleic acid, inverted terminal repeats of adeno-associated virus, and a tetracycline-off regulatable promoter system; tightly regulatable gene delivery vector
10/12/2010US7811813 Methods and immune modulatory nucleic acid compositions for preventing and treating disease
10/12/2010US7811812 For use in gene therapy and recombinant protein production
10/12/2010US7811791 nucleic acid ; for diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with IFN-L polypeptides
10/12/2010US7811582 Herpes viruses for immune modulation
10/12/2010US7811581 immunogens; tumor antigens; devoid of immunosuppressive domain; fusion proteins; immunotherapy
10/12/2010US7811579 Full-length genomic RNA of Japanese encephalitis virus, infectious JEV cDNA therefrom, and use thereof
10/12/2010US7811575 Diagnosis by detecting overexpression; active or passive immunization; antibodies, transgenic animals, hybridoma
10/12/2010US7811573 Targetting dendritic cells, endothelial cells, and macrophages which express integrins, to induce maturation
10/12/2010CA2419205C Anti-tnf antibodies, compositions, methods and uses
10/12/2010CA2327528C Recombinant virus expressing foreign dna encoding feline cd80, feline ctla-4 or feline cd86 and uses thereof
10/12/2010CA2308765C The use of an ox-2 protein or nucleic acid in immunomodulation
10/12/2010CA2196570C Recombinant herpesvirus of turkeys and uses thereof
10/07/2010WO2010115202A2 Methods and compositions for the specific inhibition of kras by blunt ended double-stranded rna
10/07/2010WO2010115172A2 Antigenic peptide of hsv-2 and methods for using same
10/07/2010WO2010114143A1 System for increasing activity of specific promoter, and vector carrying the system
10/07/2010WO2010114129A1 T cell receptor and nucleic acid encoding the receptor
10/07/2010WO2010114013A1 Polyion complex of double-stranded ribonucleic acid
10/07/2010WO2010113844A1 Rnai molecule for thymidylate synthase and use thereof
10/07/2010WO2010113507A1 Double-stranded molecule inhibiting the expression of gpc3
10/07/2010WO2010113172A1 Amphoteric liposomal compositions for cellular delivery of small rna molecules for use in rna interference
10/07/2010WO2010113132A1 Use of inhibitors of st3gal6 activity for modulation of adipogenesis
10/07/2010WO2010112935A1 Diagnostic test for virus
10/07/2010WO2010112569A1 Modulation of adipose triglyceride lipase for prevention and treatment of cachexia, loss of weight and muscle atrophy and methods of screening therefor
10/07/2010WO2010111891A1 Modified oligo-nucleic acid molecule, preparation method and uses thereof
10/07/2010WO2010111842A1 Antigenic determinants recognized by anti-human death receptor dr5 monoclonal antibody ad5-10, derivatives and uses thereof
10/07/2010WO2010065660A3 Biodegradable polydisulfide amines for gene delivery
10/07/2010WO2010064851A3 Mtor-targeted sirna having an interspecific cross reaction, recombination vector containing same, and pharmaceutical composition containing same
10/07/2010WO2010039543A3 Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating rna interference
10/07/2010WO2001079455A9 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN
10/07/2010US20100256221 Methods and compositions for treating neuropathic and neurodegenerative conditions
10/07/2010US20100255538 Antibodies to insulin-like growth factor i receptor
10/07/2010US20100255537 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof
10/07/2010US20100255501 Method of identifying a mhc class i restricted t cell response
10/07/2010US20100255111 Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem Cells
10/07/2010US20100255041 Remedy for the treatment of cardio-vascular diseases or disorders
10/07/2010US20100255030 Avirulent, immunogenic flavivirus chimeras
10/07/2010US20100255027 Papilloma pseudovirus and preparation
10/07/2010US20100255023 Dendritic cell vaccine compositions and uses of same
10/07/2010US20100254999 Eg-vegf nucleic acids and polypeptides and methods of use
10/07/2010US20100254945 Rnai Therapeutic for Respiratory Virus Infection
10/07/2010CA2749512A1 Antigenic determinants recognized by anti-human death receptor dr5 monoclonal antibody ad5-10, derivatives and use thereof
10/06/2010EP2236629A1 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms
10/06/2010EP2236619A2 BCL2L12 polypeptide activators and inhibitors
10/06/2010EP2236607A1 Use of inhibitors of St3Gla6 activity for modulation of adipogenesis
10/06/2010EP2236152A1 Albumin fusion proteins
10/06/2010EP2235175A1 Polypeptide-nucleic acid conjugates and uses thereof
10/06/2010EP2235033A2 Methods and compositions for increasing gene expression
10/06/2010EP1784492B1 Multiple rna polymerase iii promoter expression constructs
10/06/2010EP1745295B1 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
10/06/2010EP1456650B1 Gfats as modifiers of the p53 pathway and methods of use
10/06/2010EP1220906B1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby
10/06/2010EP1131457B1 Systemic viral/ligand gene delivery system and gene therapy
10/06/2010EP1100880B1 Urate oxidase
10/06/2010CN1616665B Targeted liposome gene delivery
10/06/2010CN101855346A PKIB and NAALADL2 for target genes of prostate cancer therapy and diagnosis
10/06/2010CN101855338A Wnt pathway stimulation in reprogramming somatic cells
10/06/2010CN101854918A Nucleic acid complex and nucleic acid delivery composition
10/06/2010CN101851636A Recombinant influenza viruses for vaccines and gene therapy
10/06/2010CN101851631A Codon-optimized EV71 VP1 gene and nucleic acid vaccine
10/06/2010CN101851625A RNA interference sequences of glucagon receptor gene
10/06/2010CN101851624A RNA interference sequences of glucagon receptor gene
10/06/2010CN101851621A Microbial molecular marker and construction and application thereof
10/06/2010CN101851619A Modified small RNA and preparation method thereof
10/06/2010CN101851618A Modified small interfering RNA and preparation method thereof
1 ... 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 ... 870